NCT05530512Recruiting
Acupuncture Therapy and Hypertension
Neuroimmune Mechanisms Underlying Electroacupuncture Effect on Vascular Function
Source: ClinicalTrials.gov · Last updated 20 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- First submitted
- 27 Aug 2022
- Start date
- 1 Jan 2023
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- University of California, Irvine
- Diseases
- High blood pressure
- NCT number
- NCT05530512
What you commit to
- Study type: Interventional
- Planned participants: 72
- From 1 Jan 2023 to the primary completion date, 31 Mar 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects will be excluded if they have coronary disease (by history or on ECG screening), conduction abnormalities on ECG consistent with left bundle branch block, cardiac arrhythmias associated with low blood pressure (\<90 mmHg), peripheral vascular disease, orthopedic disease, diabetic neuropathy or severe hypertension (BP \>170 mmHg systolic or \>110 mmHg diastolic), or any other physical or psychological illness.
Other
- Subjects will be excluded if pregnant or nursing.
- Those with known sensitivity to any topical preparations or strong reactions to medical dressings and skin tapes also will be excluded.
- Inability our or unwillingness of individual to give written informed consent.
Who the study is looking for
- Subjects from 45 to 75 years of age
- Clinically diagnosed with mild to moderate hypertension and ON or OFF medication (Office SBP \> 140 mmHg and \< 160 mmHg Or ABPM average SBP \> 130 mmHg and \< 145 mmHg), and
- No significant ECG change reflecting ischemia (i.e. ST elevation or depression) at rest will be recruited to participate in this study.
Age in the registry: 45 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Susan Samueli Integrative Health Institute Coordinator of this site? Confirm its status | Irvine | United States | Recruiting |
| University of California, Irvine, Health Sciences Medical Center Coordinator of this site? Confirm its status | Orange | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.